MX2022010804A - Uso de compuestos en el tratamiento de infecciones fungicas. - Google Patents

Uso de compuestos en el tratamiento de infecciones fungicas.

Info

Publication number
MX2022010804A
MX2022010804A MX2022010804A MX2022010804A MX2022010804A MX 2022010804 A MX2022010804 A MX 2022010804A MX 2022010804 A MX2022010804 A MX 2022010804A MX 2022010804 A MX2022010804 A MX 2022010804A MX 2022010804 A MX2022010804 A MX 2022010804A
Authority
MX
Mexico
Prior art keywords
treatment
fungal infections
compounds
compound
action
Prior art date
Application number
MX2022010804A
Other languages
English (en)
Inventor
Karen Joy Shaw
Michael Hodges
Original Assignee
Amplyx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amplyx Pharmaceuticals Inc filed Critical Amplyx Pharmaceuticals Inc
Publication of MX2022010804A publication Critical patent/MX2022010804A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe en la presente el uso del compuesto 1, un agente antifúngico con un mecanismo novedoso de acción, en el tratamiento de infecciones fúngicas.
MX2022010804A 2020-03-04 2021-03-02 Uso de compuestos en el tratamiento de infecciones fungicas. MX2022010804A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062985274P 2020-03-04 2020-03-04
PCT/US2021/020471 WO2021178406A1 (en) 2020-03-04 2021-03-02 Use of compounds in the treatment of fungal infections

Publications (1)

Publication Number Publication Date
MX2022010804A true MX2022010804A (es) 2023-01-16

Family

ID=77612811

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010804A MX2022010804A (es) 2020-03-04 2021-03-02 Uso de compuestos en el tratamiento de infecciones fungicas.

Country Status (11)

Country Link
US (1) US20230102036A1 (es)
EP (1) EP4114405A4 (es)
JP (1) JP2023516648A (es)
KR (1) KR20220148881A (es)
CN (1) CN115515599A (es)
AU (1) AU2021230529A1 (es)
BR (1) BR112022017653A2 (es)
CA (1) CA3174065A1 (es)
IL (1) IL296093A (es)
MX (1) MX2022010804A (es)
WO (1) WO2021178406A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
WO2012060448A1 (ja) * 2010-11-05 2012-05-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
WO2019113542A1 (en) * 2017-12-07 2019-06-13 Amplyx Pharmaceuticals, Inc. Heterocycle substituted pyridine derivative antifungal agents
US20210290644A1 (en) * 2018-08-31 2021-09-23 Amplyx Pharmaceuticals, Inc. Compounds and methods for treating fungal infections
MX2022016179A (es) * 2020-06-17 2023-04-20 Amplyx Pharmaceuticals Inc Compuestos y metodos para tratar infecciones fungicas.

Also Published As

Publication number Publication date
EP4114405A1 (en) 2023-01-11
EP4114405A4 (en) 2024-03-13
WO2021178406A1 (en) 2021-09-10
KR20220148881A (ko) 2022-11-07
CN115515599A (zh) 2022-12-23
IL296093A (en) 2022-11-01
AU2021230529A1 (en) 2022-09-29
US20230102036A1 (en) 2023-03-30
JP2023516648A (ja) 2023-04-20
BR112022017653A2 (pt) 2022-10-18
CA3174065A1 (en) 2021-09-10

Similar Documents

Publication Publication Date Title
MX2023005160A (es) Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma.
MX2022016515A (es) Nuevo inhibidor de la secrecion de acido y uso del mismo.
MX2020001807A (es) Composicion antimicrobiana de limpieza.
CL2018001407A1 (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cáncer
WO2018191692A8 (en) Methods for treating fungal infections
MX2022010804A (es) Uso de compuestos en el tratamiento de infecciones fungicas.
CL2019000857A1 (es) Compuestos heterocíclicos y su uso para prevenir o tratar las infecciones bacterianas.
MX2021008868A (es) Tela de base revestida para bolsa de aire y bolsa de aire que incluye la misma.
MX2021003430A (es) Nuevos oxadiazoles.
TWD222825S (zh) 抑菌盒
EP3674290A3 (en) Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound
BR112022014321A2 (pt) Composto antibacteriano de cefalosporina e aplicação farmacêutica do mesmo
MX2019002234A (es) Compuesto de 1-fenil-3-carbamoil urea y uso del mismo.
AR127873A1 (es) Composición que contiene un ramnolípido
MX2021011688A (es) Combinaciones utiles en un metodo para tratar sarcoma.
WO2020176610A8 (en) Method for treating a multiple myeloma
MD4745B1 (ro) Compusul 2,5,11,14-tetraazatriciclo-[13,3,1,16,10]-icosa-1(19),6,8,10(20),15,17-hexaen-3,4,12,13-tetraontetraoximă bis(N,N-dimetilformamidă) cu activitate antibacteriană şi antifungică
AR053350A1 (es) Una oxindoloxazolidinona como agente antibacteriano
EA202193146A1 (ru) Противогрибковые агенты для деколонизации candida auris
MX2022011313A (es) Materiales compuestos antimicrobianos mejorados que contienen wolframio.
TR202015971A2 (tr) Bor i̇laveli̇ anti̇fungal krem
JP1704429S (ja) 消毒液ディスペンサー
JP1704426S (ja) 消毒液ディスペンサー
JP1704427S (ja) 消毒液ディスペンサー
JP1704428S (ja) 消毒液ディスペンサー